top of page

- Mar 14, 2019

ATXA attends BioCapital Europe

ATXA Therapeutics is attending BioCapital Europe in Amterdam today. #Lifesciences #investment

Recent Posts

NTP42 Demonstrates Key Cardioprotective Benefits in Newly-published Preclinical Findings

ATXA Therapeutics receives Funding through the European Innovation Council Accelerator Programme

ATXA Presentation at ERS International Congress 2022

bottom of page